TARGAXAN

This brand name is authorized in Finland, Ireland, UK.

Active ingredients

The drug TARGAXAN contains one active pharmaceutical ingredient (API):

1	Rifaximin UNII L36O5T016N - RIFAXIMIN
	Rifaximin is an antibacterial agent of the rifamycin class that inhibits bacterial RNA synthesis. Rifaximin has a broad antimicrobial spectrum against most of the Gram-positive and -negative, aerobic and anaerobic bacteria responsible for intestinal infections.
	Read more about Rifaximin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TARGAXAN Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07AA11	Rifaximin	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	530732
GB	Medicines & Healthcare Products Regulatory Agency	218749, 374198, 380157
IE	Health Products Regulatory Authority	61720